Gerrit J. C. van den Dool
President chez Sigma-Aldrich (Switzerland) Holding AG
Profil
Gerrit J.
C.
van den Dool currently works at Gyros AB, as Director, Sigma Entity One Ltd., as Director from 2014, Gyros Protein Technologies AB, as Non-Executive Director from 2017, and Sigma-Aldrich (Switzerland) Holding AG, as President.
Postes actifs de Gerrit J. C. van den Dool
| Sociétés | Poste | Début |
|---|---|---|
Sigma Entity One Ltd.
 Sigma Entity One Ltd. Miscellaneous Commercial ServicesCommercial Services Sigma Entity One Ltd. provides solid-form research services to the pharmaceutical and biotech markets. The company was founded by David Tapolczay and Daniel Rowland Cowell on July 16, 2003 and is headquartered in Gillingham, the United Kingdom. | Directeur/Membre du Conseil | 18/03/2014 |
Gyros Protein Technologies AB
 Gyros Protein Technologies AB Medical SpecialtiesHealth Technology Gyros Protein Technologies AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. It provides sample preparation, synthesis and bioanalytical tools for biotherapeutics discovery, development and bioprocessing. The company was founded in March 2016 and is headquartered in Uppsala, Sweden. | Directeur/Membre du Conseil | 23/01/2017 |
Gyros AB
 Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | Directeur/Membre du Conseil | - |
Sigma-Aldrich (Switzerland) Holding AG
 Sigma-Aldrich (Switzerland) Holding AG Medical SpecialtiesHealth Technology Sigma-Aldrich (Switzerland) Holding AG develops, manufactures, and distributes components for medical devices. The company was founded on August 3, 1950 and is headquartered in Buchs, Switzerland. | President | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Gyros AB
Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | Health Technology |
Sigma Entity One Ltd.
Sigma Entity One Ltd. Miscellaneous Commercial ServicesCommercial Services Sigma Entity One Ltd. provides solid-form research services to the pharmaceutical and biotech markets. The company was founded by David Tapolczay and Daniel Rowland Cowell on July 16, 2003 and is headquartered in Gillingham, the United Kingdom. | Commercial Services |
Sigma-Aldrich (Switzerland) Holding AG
Sigma-Aldrich (Switzerland) Holding AG Medical SpecialtiesHealth Technology Sigma-Aldrich (Switzerland) Holding AG develops, manufactures, and distributes components for medical devices. The company was founded on August 3, 1950 and is headquartered in Buchs, Switzerland. | Health Technology |
Gyros Protein Technologies AB
Gyros Protein Technologies AB Medical SpecialtiesHealth Technology Gyros Protein Technologies AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. It provides sample preparation, synthesis and bioanalytical tools for biotherapeutics discovery, development and bioprocessing. The company was founded in March 2016 and is headquartered in Uppsala, Sweden. | Health Technology |
